Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
NASDAQ
NYSE
NYSE American
OTC Markets
ETFs
Canadian ETFs
US ETFs
Cryptocurrency
Currencies
Commodities
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Real Time & Level II Data
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Soligenix Inc.
SNGX
Healthcare
Biotechnology
Soligenix Inc is a late-stage biopharmaceutical company based in the United States. It focuses on developing and commercializing products...
to treat rare diseases where there is an unmet medical need. The company operates through two business segments namely Specialized BioTherapeutics and Public Health Solutions. It generates maximum revenue from Public Health Solutions with active development programs for RiVax, its ricin toxin vaccine candidate, SGX943, its therapeutic candidate for antibiotic resistant and emerging infectious disease, and its research programs to identify and develop novel vaccine candidates targeting viral infection including Ebola, Marburg and SARS-CoV-2 (the cause of COVID-19).
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (NDAQ:SNGX)
New Post
View:
Posts & Comments
Threaded Posts
(6)
•••
Shanemorg58
X
Post by
Shanemorg58
on Jan 12, 2023 10:54am
Strong Hold!
Soligenix On Track to Deliver Important Front-Line Treatment to US Market in 2024!! Super excited for whats coming. https://finance.yahoo.com/news/soligenix-track-deliver-important-front-133000799
...more
(6)
•••
Shanemorg58
X
Post by
Shanemorg58
on Nov 17, 2022 11:57am
upcoming webinar!
https://us06web.zoom.us/webinar/register/WN_bIGC3Z_OT5q8RVoQvlMfwg Sign up for the upcoming webinar that will cover late stage pipeline work and Q4 2022 milestones!
(0)
•••
HariboSpeedPeak
X
Post by
HariboSpeedPeak
on Jul 21, 2022 4:59pm
Benzinga Article on Soligenix
Definitely worth the read if youre thinking about investing in Soligenix or already have. Some great stuff in this article https://www.benzinga.com/general/biotech/22/07/28139372/soligenix-shares
...more
(0)
•••
HariboSpeedPeak
X
Post by
HariboSpeedPeak
on Jul 20, 2022 2:28pm
Soligenix HyBryte Phase 3 Flash Study, Significant Results
Soligenix’s successful Phase 3 FLASH study evaluating HyBryteTM for the treatment of cutaneous T-cell lymphoma has been published in the Journal of the American Medical Association Dermatology. The
...more
(6)
•••
Shanemorg58
X
Post by
Shanemorg58
on May 20, 2022 12:13pm
Huge potential in 2022
https://finance.yahoo.com/news/sngx-phase-2a-trial-sgx302-143000280.html Phase 2a trial of SGX302 in psoriasis coming in the second half of 2022! Feeling bullish on this!
(6)
•••
Shanemorg58
X
Post by
Shanemorg58
on May 19, 2022 11:24am
Strong Hold!
Love seeing more insiders buying! They must be confident on whats to come. https://app.quotemedia.com/data/downloadFiling?webmasterId=101533&ref=116715658&type=HTML&symbol=SNGX&
...more
(4)
•••
borrock
X
Post by
borrock
on Nov 25, 2020 2:30pm
Future trend
ZACKS SCR IS BULLISH ON SOLIGENIX, SUGGESTING 580% UPSIDE; MULTIPLE ASSETS COMBINE TO SET UP THREE NEAR-TERM POTENTIAL CATALYSTS
...more
Thank You
Your Report has been submitted.
Report Abusive Content
×
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
{{currentVideo.storiesTitle}}:
{{story.companySymbol}}
{{story.companySymbol}}
{{story.headline}}
< Previous bulletin
Next bulletin >
The Power Play by The Market Herald
{{currentVideo.videoCaption}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous Video
{{moreVideoText}}
Next Video >
Featured News Links
Q2 Metals Initiates Phase Two of Exploration Work at Its Mia Lithium Property in James Bay, Quebec
Canada Nickel Continues to Intersect High-grade, Near-surface Mineralization at Texmont Project
Noble Mineral Exploration to Acquire a Mining Claim in Newfoundland Covering Approximately 175 Hectares
DehydraTECH Licensing Revenues increases 5x and Hits Another Quarterly Record with New Licensees
Exclusive Insights on the Precious Metals Industry and What to Expect in 2023 – Download free report